Delirium from nicotine withdrawal in neuro-ICU patients

Neurology

Volumn 57, Issue 3, 2001, Pages 551-553

  Mayer, S A ^a,b   Chong, J Y ^a   Ridgway, E ^a   Min, K C ^a   Commichau, C ^a   Bernardini, G L ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

^b NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NICOTINE;

ADULT; AGED; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CRITICAL ILLNESS; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO;

EID: 0035859910     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.3.551     Document Type: Article

References (10)

1. Delirium in hospitalized older patients
2. Terminal restlessness and nicotine withdrawal
3. Nicotine withdrawal as an etiologic factor in delirium
4. Does delirium contribute to poor hospital outcomes? A three site epidemiologic study
5. Delirium: The occurrence and persistence of symptoms among elderly hospitalized patients
6. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal
7. Characterization of tobacco withdrawal symptoms: Transdermal nicotine reduces hunger and weight gain
8. High dose nicotine patch treatment. Percentage of replacement and smoking cessation
9. Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway